This R21 grant from the National Institute on Drug Abuse (NIDA) is for supporting research projects aimed at enhancing our understanding of drug use, abuse, and addiction. Specifically, it seeks to explore the nature, extent, distribution, etiology, and consequences of substance use across various populations, including individuals, families, and communities. The program encourages applications that delve into multiple levels of causation, embracing transdisciplinary approaches and novel methodologies. This includes investigating the interplay of genetic, environmental, and developmental factors, and how social environments influence health outcomes. Furthermore, NIDA welcomes proposals that creatively and cost-effectively utilize existing data from NIH and other funders to advance drug abuse epidemiology and etiology research.
Opportunity ID: 99714
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-11-231 |
Funding Opportunity Title: | Epidemiology of Drug Abuse (R21) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jun 16, 2011 |
Last Updated Date: | – |
Original Closing Date for Applications: | Sep 07, 2014 |
Current Closing Date for Applications: | Sep 07, 2014 |
Archive Date: | Oct 08, 2014 |
Estimated Total Program Funding: | – |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Special district governments Independent school districts City or township governments County governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA), is intended to support research projects with the R21 mechanism to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups. This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-11-231.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.279 | ADOBE-FORMS-B1 | ADOBE-FORMS-B1 | PKG00059532 | Sep 16, 2011 | Sep 24, 2013 | View |
93.279 | FORMS-C | Use for due dates after 9/24/2013 | PKG00181261 | Sep 16, 2013 | Sep 07, 2014 | View |
Package 1
Mandatory forms
99714 RR_SF424_1_2-1.2.pdf
99714 RR_OtherProjectInfo_1_3-1.3.pdf
99714 RR_KeyPersonExpanded_1_2-1.2.pdf
99714 PerformanceSite_1_4-1.4.pdf
99714 PHS398_ResearchPlan_1_3-1.3.pdf
99714 PHS398_CoverPageSupplement_1_4-1.4.pdf
99714 PHS398_Checklist_1_3-1.3.pdf
Optional forms
99714 RR_Budget-1.1.pdf
99714 RR_SubawardBudget-1.2.pdf
99714 PHS_CoverLetter_1_2-1.2.pdf
99714 PHS398_ModularBudget-1.1.pdf
Package 2
Mandatory forms
99714 RR_SF424_2_0-2.0.pdf
99714 PHS398_ResearchPlan_2_0-2.0.pdf
99714 PHS398_CoverPageSupplement_2_0-2.0.pdf
99714 RR_KeyPersonExpanded_2_0-2.0.pdf
99714 RR_OtherProjectInfo_1_3-1.3.pdf
99714 PerformanceSite_2_0-2.0.pdf
Optional forms
99714 RR_SubawardBudget30_1_3-1.3.pdf
99714 PlannedReport-1.0.pdf
99714 PHS398_CumulativeInclusionReport-1.0.pdf
99714 PHS398_ModularBudget_1_2-1.2.pdf
99714 RR_Budget_1_3-1.3.pdf